Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey
Loading...
Files
Published version
Published version
Date
2019-07-04
Authors
Bogdanet, Delia
Reddin, Catriona
Macken, Esther
Griffin, Tomás P.
Fhelelboom, Narjes
Biesty, Linda M.
Thangaratinam, Shakila
Dempsey, Eugene M.
Crowther, Caroline
Galjaard, Sander
Journal Title
Journal ISSN
Volume Title
Publisher
Springer
Published Version
Abstract
Gestational diabetes mellitus (GDM) is linked with a higher lifetime risk for the development of impaired fasting glucose, impaired glucose tolerance, type 2 diabetes, the metabolic syndrome, cardiovascular disease, postpartum depression and tumours. Despite this, there is no consistency in the long-term follow-up of women with a previous diagnosis of GDM. Further, the outcomes selected and reported in the research involving this population are heterogeneous and lack standardisation. This amplifies the risk of reporting bias and diminishes the likelihood of significant comparisons between studies. The aim of this study is to develop a core outcome set (COS) for RCTs and other studies evaluating the long-term follow-up at 1 year and beyond of women with previous GDM treated with insulin and/oral glucose-lowering agents.
Description
Keywords
Core outcome set , Gestational diabetes mellitus , Insulin , Oral hypoglycaemic agents
Citation
Bogdanet, D., Reddin, C., Macken, E., Griffin, T.P., Fhelelboom, N., Biesty, L., Thangaratinam, S., Dempsey, E., Crowther, C., Galjaard, S. and Maresh, M. (2019) 'Follow-up at 1 year and beyond of women with gestational diabetes treated with insulin and/or oral glucose-lowering agents: a core outcome set using a Delphi survey'. Diabetologia, 62(11), pp. 2007-2016. doi:10.1007/s00125-019-4935-9